CliffBio
small molecule

MICAFUNGIN IN SODIUM CHLORIDE 0.9%

MICAFUNGIN SODIUM

Loss of exclusivityDecember 2037latest FDA-listed patent expiry
CompanyBaxter Healthcare Corp →View the full company profile on CliffBio

Drug detail

Brand nameMICAFUNGIN IN SODIUM CHLORIDE 0.9%
Active ingredientMICAFUNGIN SODIUM
StrengthEQ 50MG BASE/50ML (EQ 1MG BASE/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalSeptember 2023
Marketing statusRX

Listed patents

PatentExpiresType
12403173December 2037product

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

MICAFUNGIN IN SODIUM CHLORIDE 0.9% patent cliff — loss of exclusivity December 2037 | CliffBio